Biosite and Beckman Coulter in BNP (b-type natriuretic peptide) test deal
This article was originally published in Clinica
Executive Summary
Beckman Coulter is to make a b-type natriuretic peptide (BNP) test for the diagnosis and assessment of heart failure risk, to be marketed by Biosite.